(3-Cyclopropyl-4-fluorophenyl)methanamine

Catalog No. :
ACFZAV078
CAS No. :
1063733-90-3
Molecular Formula :
C10H12FN
Molecular Weight :
165.21

IUPAC Name:(3-cyclopropyl-4-fluorophenyl)methanamine

(3-Cyclopropyl-4-fluorophenyl)methanamine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg96%$69.00Login to see priceIn stockInquiry
250mg96%$117.00Login to see priceIn stockInquiry
1g96%$293.00Login to see priceIn stockInquiry
5g96%$1043.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(3-Cyclopropyl-4-fluorophenyl)methanamine
IUPAC Name(3-cyclopropyl-4-fluorophenyl)methanamine
Molecular FormulaC10H12FN
Molecular Weight165.21
SMILESNCC1=CC=C(F)C(C2CC2)=C1
InChI KeyAEBMJKAYVCSCBJ-UHFFFAOYSA-N
Synonym(3-cyclopropyl-4-fluorophenyl)methanamine;3-Cyclopropyl-4-fluorobenzenemethanamine;1-(3-cyclopropyl-4-fluorophenyl)methanamine;(3-Cyclopropyl-4-fluorophenyl);Benzenemethanamine, 3-cyclopropyl-4-fluoro-;(3-Cyclopropyl-4-fluorophenyl)methanamine - [C89458]
CAS No.1063733-90-3
PubChem CID40151800

Safety Data

Pictogram
CorrosiveHarmful or irritant
Signal Word
Danger
Hazard Statement(s)
H302-H314
Precautionary Statement(s)
P264-P270-P271-P280-P303+P361+P353-P304+P340-P305+P351+P338-P310-P330-P331-P363-P403+P233-P501

Synthetic Route by SureRoute

1. ACFZAV078 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACFZAV078 route product structure diagram
    ACFZAV0781063733-90-3 In Stock
Inquiry

2. ACFZAV078 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFZAV078 route product structure diagram
    ACFZAV0781063733-90-3 In Stock
Inquiry

Comments (0)